Crescent Biopharma (CBIO) Earnings Date & Reports

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CBIO is expected to report earnings to fall 10.59% to -66 cents per share on November 05

Crescent Biopharma CBIO Stock Earnings Reports

Q3'26

Est.

$-0.66

Q2'26

Beat

by $0.04

Q1'26

Beat

by $0.18

Q1'25

Beat

by $0.10

The last earnings report on July 30 showed earnings per share of -74 cents, beating the estimate of -78 cents. With 105.80K shares outstanding, the current market capitalization sits at 720.65M.

View a ticker or compare two or three

CBIO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for CBIO